Saturday, July 12, 2014

Medisse, A Dutch biomaterial company, successfully treated the first patient with the FlexiSurge Adhesion Barrier to me in about 5 years....

EDE, The Netherlands--()--Medisse BV, a leading innovator and developer of synthetic resorbable soft tissue implants, today announced the successful treatment of the first patient in a clinical trial for its first innovation, FlexiSurge® Adhesion Barrier, which is designed to reduce adhesions formed after open colorectal surgery procedures. The study, currently underway in the Netherlands, marks a significant milestone in the development of the Company’s first product to revolutionize patient care.
“We are happy to have successfully treated the first patient in the FlexiSurge study”
The study, being conducted in three hospitals in the Netherlands, will the safety of 

Friday, May 30, 2014

Dr. Kate Scannell: C-Sections and maternal mortality -- new data, new concerns

By Dr. Kate Scannell, contributing columnist © 2014 Bay Area News Group

The last few months have proved fertile ground for newsworthy reports of universal interest concerning the health of pregnant women and newborns, the likely overuse of C-sections, and the role of hospitals and health care providers in shaping parental decisions about childbirth.
Beginning with a report from the Centers for Disease Control and Prevention, we learned last December that nearly 1 in 3 women giving birth in the U.S. did so by cesarean section. That whopping rate dramatically exceeded the World Health Organization's recommended upper limit of 10 to 15 percent.
This month, we subsequently learned about wild variations in cesarean rates within our own country. After analyzing data from 1,500-plus hospitals in 22 states, Consumer Reports documented C-section rates that ranged between 4 and 57 percent among comparable groups of pregnant women. For two hospitals, mere miles away, rates were 55 versus 15 percent.
Why such profound variations? Should our standards of medical practice be so flexible?
Click link below to read the rest

adhesiologicums adhesions blog: Medical Headlines for Patients with Adhesions

adhesiologicums adhesions blog: Medical Headlines for Patients with Adhesions

Friday, May 16, 2014

Medical Headlines for People w Adhesions ARD

Medical Headlines for People w Adhesions ARD

Cost-control plan for health care could cost you    photo
WASHINGTON (AP) — You just might want to pay attention to the latest health insurance jargon. It could mean thousands of dollars out of your pocket. The Obama administration has given the go-ahead for a new cost-control strategy called "reference pricing." It lets insurers and employers put a...

Surgery safer with teamwork, training   [external]
Briefings of doctors and nurses on teams before and after each operation cut the death rate 18%, a study finds.

Reading Pain in a Human Face   [external]
Researchers have found that a computer is much better than people are at telling the difference between real and faked pain, a discovery that may lead to methods to detect children’s pain and to treat depression.

Data Murky on Fertility Rates   [external]
In the multibillion-dollar fertility industry, there is little enforcement of regulations that require clinics to report their success rates.

Friday, May 02, 2014

adhesiologicums adhesions blog: Medical Headlines for People with ARD Adhesions

adhesiologicums adhesions blog: Medical Headlines for People with ARD Adhesions

Johnson and Johnson Issues Alert For Fibroid Surgery Devices' Potentially Cancer Causing Process

Johnson and Johnson has stopped selling fibroid surgery devices Wednesday, due to potential cancer risks associated with their use.  
The company told The Wall Street Journal more details were needed from medical professionals before sales resume.
"We believe that suspending the commercialization of these products until their role is better understood and redefined by the medical community is the appropriate course of action at this time," Johnson and Johnson said in the statement.
Johnson and Johnson told customers in an official statement that the decision did not come easy.
"This decision was not made lightly because we are well aware of the significant benefits that these products can offer many women," the company said."Since 1998, Ethicon's morcellation devices have enabled thousands of patients to have minimally invasive surgical hysterectomy and myomectomy procedures, instead of more invasive surgical procedures."
This process, known as morcellation, slashes body tissue for removal to help prevent cancer from spreading to other areas. But now, the United States Food and Drug Administration is concerned that exposed tissue could cause cancer to spread.

EndoTimes: Dr. Drew doesn’t understand your “garbage” diagnosis ~ Endometriosis and Interstitial Cystitis

EndoTimes: Dr. Drew doesn’t understand your “garbage” diagnosis ~ Endometriosis and Interstitial Cystitis

Thursday, April 24, 2014

Chronic Abdominal Pain Can Indicate Adhesion Related Disorder

Does your abdomen generally hurt or have odd vague pains that are difficult to describe to your health care provider? Does it hurt after you eat, during a bowel movement or during sex? Have you been through imaging only to be told, “Nothing is wrong”? Consider adhesion related disorder (ARD).

Read article here

Sometimes adhesions are a good thing

To Breathe Upside-Down, Sloths Tape Organs To Their Ribs

If you spent a lot of your life hanging upside-down, you’ve got a problem. Your liver, kidneys, stomach and other internal organs would press down upon your lungs and diaphragm, making it marginally harder to breathe. This won’t matter in the short term but in the long run, you’d spend a lot more energy on the simple act of inflating your lungs.
So, how do sloths cope? They live life in the slow lane, and they don’t have a lot of spare energy to play with. They also spend a lot of time hanging upside-down from branches. Cartoon drawings usually have them hanging horizontally, which isn’t a problem. But if you spend enough time watching wild sloths, as Rebecca Cliffe from Swansea University has done, you’ll see that they often hang vertically upside-down, to reach the youngest and most tender leaves on the furthest, smallest branches.
Cliffe knows their secret. She has discovered that sloths effectively tape their internal organs to their ribs and hips, preventing them from pressing down on the lungs.
Cliffe spends much of her time in Costa Rica’s Sloth Sanctuary, where she tries to understand the lives of these little-studied but adorable animals. The sanctuary has been caring for rescued sloths for more than 20 years, and the staff often have to dissect individuals that die of natural causes. In the process, they noticed thin fibrous sheets attached to the sloths’ internal organs, rather like the membrane that connects your tongue to the bottom of your mouth. “They’re stringy, tough and a little rubbery,” says Cliffe. 


At first the team assumed that these “fibrinous adhesions” were scar tissues from previous injuries. But slowly, they noticed that the adhesions were always in the same place. They anchor the liver and stomach to the lower ribs, and the kidneys to the hip bones. They’re not scars. They’re normal parts of the sloths’ bodies, and they ensure that the ribs always bear the weight of the viscera.
The team also measured the lung capacity and breathing rates of their sloths, and made them wear small data-loggers to work out how much time they spend upside-down. Based on their data, they estimated that an inverted sloth would spend between 7 and 13 percent more energy on breathing if it wasn’t for its adhesions.
“For many mammals, an energy saving of 7 to 13 percent wouldn’t be particularly game-changing,” says Cliffe. In fact, some mammals like howler monkeys do regularly hang inverted without any organ-anchors. The difference is that “sloths have virtually no flexibility in their energy budget. They generate just about enough energy from their diet to move when and where required, but there is not much left in the tank afterwards. To a sloth, an energy saving of 7 to 13 percent is quite a big deal.”
They also take a very long time to digest their food, and they only urinate and defecate once a week. Most of the time, a sloth is carrying a third of their body weight in waste matter, which means that its stomach and bowels are very heavy. “It would be energetically very expensive, if not completely impossible, for a sloth to lift this extra weight with each breath were it not for the adhesions,” says Cliffe.
Use link above to finish the article.

Sunday, April 20, 2014

Mirena Lawsuits Move Forward in New Jersey Litigation, As Court Schedules May Conference, Bernstein Liebhard LLP Reports

The Firm is representing clients who filed Mirena IUD lawsuits in this proceeding after allegedly suffering serious Mirena complications that followed spontaneous migration of the device.

New York, New York (PRWEB) April 18, 2014
More than 700 Mirena lawsuits ( filed on behalf of women who were allegedly injured due to spontaneous migration of the IUD continue to move forward in a consolidated litigation underway in New Jersey’s Bergen County Superior Court, Bernstein Liebhard LLP reports. Court documents indicate that the proceeding’s next Case Management Conference has been scheduled for May 13, 2014, at 2:00 p.m. According to an Order dated April 1, 2014, the parties have been directed to submit a proposed agenda to the Court at least seven days prior to the conference. (In Re: Mirena Litigation; Case No. 297)
“Our Firm is representing numerous women in this proceeding who allegedly suffered serious Mirena complications after their IUD spontaneously migrated from its proper position in the uterus. We are pleased to see this litigation moving forward,” says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm is currently offering free Mirena lawsuit evaluations to women who may have been injured due to the spontaneous migration of their IUD.
Mirena IUD Lawsuits
The Mirena IUD is a long-acting contraceptive device that is manufactured by Bayer Healthcare Pharmaceuticals. The product was initially approved as a method of birth control in 2000 by the U.S. Food & Drug Administration (FDA), which in 2009 expanded its approved uses to include the treatment of heavy menstrual bleeding in women who wish to use an IUD as their method of contraception. According to a report that aired on 7 Action News this past summer, the U.S. Food & Drug Administration (FDA) has received more than 70,000 complaints involving Mirena, including thousands that detail cases of device dislocation and uterine perforation, since the IUD was first launched.*
In December 2009, the FDA issued a Warning Letter to Bayer Healthcare Pharmaceuticals after finding that one of the company’s Mirena promotions made misleading claims about the safety and efficacy of the IUD.
According to court documents, all of the Mirena lawsuits pending in the New Jersey litigation allege that plaintiffs sustained uterine perforations, adhesions, infections, and other serious Mirena complications due to spontaneous migration of the IUD, even though the device had been properly inserted by a healthcare provider. The lawsuits further allege that Bayer has a history of overstating the IUD’s benefits and downplaying its risks. Finally, plaintiffs claim that the company has not provided adequate warnings regarding its propensity to spontaneous migrate from its proper position in the uterus, and point out that the Mirena label only states that migration may occur if the uterus is punctured during insertion.
Court records indicate that more than 1,000 lawsuits involving alleged Mirena complications are now pending in courts throughout the country. In addition to the New Jersey litigation, nearly 500 additional lawsuits have been consolidated for pretrial proceedings in the U.S. District Court, Southern District of New York. (In re: Mirena IUD Products Liability Litigation, MDL No. 2434)
Women who have allegedly experienced serious Mirena complications related to spontaneous migration of the IUD may be entitled to financial compensation for their injury-related damages. Learn more about potential Mirena complications at Bernstein Liebhard LLP’s website, or visit the Firm’s Facebook page: For a free legal consultation, please call 800-511-5092.
*, 7 Action News, August 27, 2013
About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the Plaintiffs’ Hot List, recognizing the top plaintiffs firms in the country, for the past 12 consecutive years. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list every year since the list was first published in 2003.
Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
ATTORNEY ADVERTISING. © 2014 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Contact Information:
Felecia L. Stern, Esq.
Bernstein Liebhard LLP
info (at) consumerinjurylawyers (dot) com

Wednesday, April 16, 2014

Massachusetts cannot ban FDA-approved painkiller, judge rules

A federal judge on Tuesday blocked an effort by Massachusetts Gov. Deval L. Patrick to ban sales of a controversial new painkiller in the state, saying the governor’s move was preempted by federal law and could harm people who need the drug for pain relief.
In a five-page order, U.S. District Judge Rya W. Zobel sided with the drug’s California-based manufacturer, Zogenix, which had argued that Patrick had no right to bar a medication that the Food and Drug Administration has deemed safe and effective.

Tuesday, April 15, 2014

More Doctors Adhesions and Adhesiolysis Croatia Russia

Department of Gynecology and Obstetrics, Zabok General Hospital, Zabok 
Dr. med Miroslav Kopjar Professor, M.D., Ph.D 

Professor L. Adamyan, member of the Russian Academy of Medical Sciences. 
Chief of the Department of Operative Gynecology Scientific Center for Obstetrics, Gynecology and Perinatology of Russian Academy of Medical Sciences. 
President of the Russian Association of Endometriosis. 
Vice-President of the Russian Association of Gynecologic Endoscopists 

A New Hysterectomy Procedure Eliminates Massive Scarring and Long Recovery Time. So Why Aren’t More Doctors On Board?

A new procedure for hysterectomies, done via robotic arm via a single incision, results in no scarring and little downtime. But the procedure has yet to gain the support of the medical community.
Click here for full article:

Article features info on single port robotic hysterectomy w Da Vinci Systems

Monday, April 14, 2014

UK Doc Ellis Downes MD

Ellis Downes, MD 
Hysterectomy & Alternatives 
Cuttings Hospital 

FDA: Use Sicker Patients in Clinical Trials

By  David Pittman , Washington Correspondent, MedPage Today

WASHINGTON -- The FDA is taking steps to include more patients with multiple chronic conditions in clinical trials of new drugs, believing such patients are too frequently excluded from new drug studies.
Pharmaceutical companies routinely exclude the sickest patients from studies, fearing complications they may suffer from the drug candidates, but, as a result, the studies don't provide a glimpse of the treatment's "real world" effect.
To counter this, the FDA recently issued a memo to its new drug reviewers asking them to work with drug manufacturers to include a broader population in trials more regularly.
"The whole point of this is that if there really are differences in response -- either favorable or unfavorable -- among subsets of the population, what clinicians need is to know about it, so they can either watch for them or use a different drug," Bob Temple, MD, deputy director for clinical science at the FDA's Center for Drug Evaluation and Research, told reporters Friday. "This adds to the information available."
The internal memo, which effectively changes FDA policy, will force those conducting trials to focus more on their inclusion criteria and avoid unnecessary exclusions.

Sunday, April 13, 2014

Adhesion Incidence and Severity Vary by Surgical Procedure

By Jeannette Wick |
 MExperts estimate approximately 93% of patients who have undergone laparoscopic surgery develop abnormal fibroid bands that bind organ surfaces to the abdominal wall after a second surgery. Many adhesions are asymptomatic, but in some patients, they can cause pain, small bowel obstruction and other postoperative issues, as well as increase cost and complicate surgical suite workload. As surgeons underestimate the rate of adhesion development given that up to 93% of consent forms don’t address them, the March 2014 issue of Surgery Today contained a systematic review estimating the formation rate, distribution, and severity of postoperative adhesions in abdominal surgery patient.
Full article

Friday, April 11, 2014

Benefits and harms of adhesion barriers for abdominal surgery: a systematic review and meta-analysis

Richard P G ten Broek MD a Corresponding AuthorEmail AddressMartijn W J Stommel MD aChema Strik MD aProf Cornelis J H M van Laarhoven MD a,Fred
erik Keus MD bProf Harry van Goor FRCS a



Formation of adhesions after peritoneal surgery results in high morbidity. Barriers to prevent adhesion are seldom applied, despite their ability to reduce the severity of adhesion formation. We evaluated the benefits and harms of four adhesion barriers that have been approved for clinical use.


In this systematic review and meta-analysis, we searched PubMed, CENTRAL, and Embase for randomised clinical trials assessing use of oxidised regenerated cellulose, hyaluronate carboxymethylcellulose, icodextrin, or polyethylene glycol in abdominal surgery. Two researchers independently identified reports and extracted data. We compared use of a barrier with no barrier for nine predefined outcomes, graded for clinical relevance. The primary outcome was reoperation for adhesive small bowel obstruction. We assessed systematic error, random error, and design error with the error matrix approach. This study is registered with PROSPERO, number CRD42012003321.


Our search returned 1840 results, from which 28 trials (5191 patients) were included in our meta-analysis. The risks of systematic and random errors were low. No trials reported data for the effect of oxidised regenerated cellulose or polyethylene glycol on reoperations for adhesive small bowel obstruction. Oxidised regenerated cellulose reduced the incidence of adhesions (relative risk [RR] 0·51, 95% CI 0·31—0·86). Some evidence suggests that hyaluronate carboxymethylcellulose reduces the incidence of reoperations for adhesive small bowel obstruction (RR 0·49, 95% CI 0·28—0·88). For icodextrin, reoperation for adhesive small bowel obstruction did not differ significantly between groups (RR 0·33, 95% CI 0·03—3·11). No barriers were associated with an increase in serious adverse events.


Oxidised regenerated cellulose and hyaluronate carboxymethylcellulose can safely reduce clinically relevant consequences of adhesions.



Factors in Adhesions Reformation

Boston Doc's first to use Google glasses

BOSTON (CBS) — Doctors at Beth Israel Deaconess Medical Center are the first in the country to be using Google Glass technology to save valuable seconds.
Google introduced the Glass technology in 2013 and only a limited number of people have been able to try it. Beth Israel Deaconess is the first hospital in the world to use the high-tech classes for direct patient care.
Dr. Steven Horng is an emergency room physician who spearheaded a program to bring the technology to the ER.
What they do is project an image of the patient’s screens so information about the patient is obtained right away. Information like the patient’s name, their past medical history, even X-rays can all come up with Google Glass and could be life-saving, especially if a patient can’t communicate or doesn’t know their allergies and medications.